Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA lifts clinical hold on phase I NHL study of PPI-2458

June 25, 2004

Exanta launched in Germany

June 25, 2004

Good safety profile reported for AP-23573 in patients with refractory tumors

June 25, 2004

North American phase III trial initiated for Alzhemed

June 25, 2004

New European approval for Herceptin

June 25, 2004

Remicade approved in E.U. for early rheumatoid arthritis

June 25, 2004

Topical tacrolimus found to improve skin lesions in patients with connective tissue disease

June 25, 2004

Metabolic conversion of anticancer agent SD-2007 to apicidin in rats

June 25, 2004

Green tea extract may reverse tetracycline resistance

June 25, 2004

Bevacizumab demonstrates substantial clinical activity

June 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...